A carregar...
NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer
OBJECTIVES: NY-ESO-1 is a cancer testis antigen and a promising target for immunotherapy. The purpose of this study was to determine the expression frequency, immunogenicity, and clinical impact of NY-ESO-1 in ovarian cancer. METHODS: Immunohistochemistry (IHC), reverse-transcription polymerase chai...
Na minha lista:
| Publicado no: | Gynecol Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5497581/ https://ncbi.nlm.nih.gov/pubmed/28392127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2017.03.509 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|